Literature DB >> 15715936

Effects of spider Macrothele raven venom on cell proliferation and cytotoxicity in HeLa cells.

Li Gao1, Bao-en Shan, Jing Chen, Jian-hui Liu, Da-xiang Song, Bao-cheng Zhu.   

Abstract

AIM: To examine the effect of venom from the spider Macrothele raven on cell proliferation and cytotoxicity in human cervical carcinoma, HeLa cells.
METHODS: Morphological and biochemical signs of apoptosis appeared using acridine orange-ethidium bromide (AO/EB) staining. Marked morphological changes in HeLa cells after treatment with spider venom were observed using scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Cell proliferation and cytotoxicity were determined by [methyl-3H] thymidine assay ([3H]TdR) and lactate dehydrogenase (LDH) release, respectively. DNA fragmentation and cell cycle distribution were monitored using flow cytometry. In addition, Western blot analysis was used to evaluate the level of caspase-3 expression. In vivo examination of the inhibition of the size of tumors in nude mice treated with spider venom was measured.
RESULTS: Marked morphological changes were observed using AO/EB staining, SEM and TEM assay. Spider venom at concentrations of 10-40 mg/L caused dose- and time-dependent inhibition of HeLa cell proliferation. The ratio of apoptosis and necrosis increased. The activity of caspase-3 was upregulated after spider venom treatment. In vivo study of tumor size revealed that tumors significantly decreased in size from controls to tumors treated for 3 weeks with spider venom (P<0.05).
CONCLUSION: The inhibition of HeLa cells by the venom of the spider Macrothele raveni was carried out in three ways: induction of apoptosis, necrosis of toxicity damage and direct lysis. Spider venom is a novel anti-tumor material both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15715936     DOI: 10.1111/j.1745-7254.2005.00052.x

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  9 in total

Review 1.  Anticancer, antimicrobial, and analgesic activities of spider venoms.

Authors:  Hassan M Akef
Journal:  Toxicol Res (Camb)       Date:  2018-03-08       Impact factor: 3.524

2.  Cytotoxic and apoptotic activities of black widow spiderling extract against HeLa cells.

Authors:  Xiaozhen Peng; Zhipan Dai; Qian Lei; Long Liang; Shuai Yan; Xianchun Wang
Journal:  Exp Ther Med       Date:  2017-04-27       Impact factor: 2.447

Review 3.  Spider-venom peptides as therapeutics.

Authors:  Natalie J Saez; Sebastian Senff; Jonas E Jensen; Sing Yan Er; Volker Herzig; Lachlan D Rash; Glenn F King
Journal:  Toxins (Basel)       Date:  2010-12-20       Impact factor: 4.546

4.  Comparative analysis of tissue-specific transcriptomes in the funnel-web spider Macrothele calpeiana (Araneae, Hexathelidae).

Authors:  Cristina Frías-López; Francisca C Almeida; Sara Guirao-Rico; Joel Vizueta; Alejandro Sánchez-Gracia; Miquel A Arnedo; Julio Rozas
Journal:  PeerJ       Date:  2015-06-30       Impact factor: 2.984

5.  Cytotoxicity of ICD-85 NPs on Human Cervical Carcinoma HeLa Cells through Caspase-8 Mediated Pathway.

Authors:  Saeed Moradhaseli; Abbas Zare Mirakabadi; Ali Sarzaeem; Morteza Kamalzadeh; Reza Haji Hosseini
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

6.  Resistance of cervical adenocarcinoma cells (HeLa) to venom from the scorpion Centruroides limpidus limpidus.

Authors:  José María Eloy Contreras-Ortiz; Juan Carlos Vázquez-Chagoyán; José Simón Martínez-Castañeda; José Guillermo Estrada-Franco; José Esteban Aparicio-Burgos; Jorge Acosta-Dibarrat; Alberto Barbabosa-Pliego
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2013-09-02

7.  A novel neurotoxin from venom of the spider, Brachypelma albopilosum.

Authors:  Yunhua Zhong; Bo Song; Guoxiang Mo; Mingwei Yuan; Hongli Li; Ping Wang; Minglong Yuan; Qiumin Lu
Journal:  PLoS One       Date:  2014-10-20       Impact factor: 3.240

8.  Spider venom components decrease glioblastoma cell migration and invasion through RhoA-ROCK and Na+/K+-ATPase β2: potential molecular entities to treat invasive brain cancer.

Authors:  Natália Barreto; Marcus Caballero; Amanda Pires Bonfanti; Felipe Cezar Pinheiro de Mato; Jaqueline Munhoz; Thomaz A A da Rocha-E-Silva; Rafael Sutti; João Luiz Vitorino-Araujo; Liana Verinaud; Catarina Rapôso
Journal:  Cancer Cell Int       Date:  2020-12-17       Impact factor: 5.722

9.  Mitochondrial activity disruption and local muscle damage induced in mice by Scolopendra polymorpha venom.

Authors:  Judith Tabullo De Robles; Francisca Fernández Valverde; Lucero Valladares Cisneros; Juana Hernández Villeda; Ayixon Sánchez-Reyes; María Del Carmen Gutiérrez
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2020-05-29
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.